Literature DB >> 27060441

Disruption of Iron Regulation after Radiation and Donor Cell Infusion.

Ekapun Karoopongse1, A Mario Marcondes2, Cecilia Yeung3, Zaneta Holman1, Kris V Kowdley4, Jean S Campbell5, H Joachim Deeg6.   

Abstract

Iron overload is common in patients undergoing hematopoietic cell transplantation (HCT). Peritransplant events, such as total body irradiation (TBI), and the effects of donor cell infusion may contribute to iron overload, in addition to disease-associated anemia and RBC transfusions. Using murine models we show complex time- and dose-dependent interactions of TBI and transplanted donor cells with expression patterns of iron regulatory genes in the liver. Infusion of allogeneic or syngeneic donor T lymphocytes increased serum iron, transiently up-regulated interleukin-6 (IL-6) and hepcidin (Hamp), and down-regulated ferroportin1 (Fpn1). After 7 to 14 days, however, changes were significant only with allogeneic cells. TBI (200 to 400 Gy) also induced IL-6 and Hamp expression but had little effect on Fpn1. TBI combined with allogeneic donor cell infusion resulted in modest early up-regulation of IL-6, followed by a decline in IL-6 levels and Hamp as well as Fpn1, and was accompanied by increased liver iron content. Injection of Fas ligand-deficient T lymphocytes from gld mice resulted in substantially lower alterations of gene expression than infusion of wild-type T cells. The agonistic anti-Fas antibody, JO2, triggered early up-regulation of Stat3 and IL-6, followed by an increase in Hamp and decreased expression of Fpn1 by 7 to 14 days, implicating Fas as a key modulator of gene expression in HCT. Minimal histologic changes were observed in mouse liver and duodenum. These data show profound and interacting effects of TBI and cell transplantation on the expression of iron regulatory genes in murine recipients. Alterations are largely related to induction of cytokines and Fas-dependent signals.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Donor cell infusion; Fas; Gene expression; Hepcidin; IL-6; Radiation

Mesh:

Substances:

Year:  2016        PMID: 27060441      PMCID: PMC5131542          DOI: 10.1016/j.bbmt.2016.03.031

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  23 in total

1.  Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

Authors:  M Murai; H Yoneyama; A Harada; Z Yi; C Vestergaard; B Guo; K Suzuki; H Asakura; K Matsushima
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease.

Authors:  K Miwa; H Hashimoto; T Yatomi; N Nakamura; S Nagata; T Suda
Journal:  Int Immunol       Date:  1999-06       Impact factor: 4.823

3.  CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications.

Authors:  Anne Janin; Christophe Deschaumes; Marjan Daneshpouy; Jérôme Estaquier; Juliette Micic-Polianski; Premavathy Rajagopalan-Levasseur; Khadija Akarid; Nicolas Mounier; Eliane Gluckman; Gérard Socié; Jean Claude Ameisen
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

4.  Fas engagement increases expression of interleukin-6 in human glioma cells.

Authors:  Chulhee Choi; G Yancey Gillespie; Nicholas J Van Wagoner; Etty N Benveniste
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

5.  Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.

Authors:  Xiang Li; Feng Xu; Ekapun Karoopongse; A Mario Marcondes; Kayoung Lee; Kris V Kowdley; Carol H Miao; Grant D Trobridge; Jean S Campbell; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-22       Impact factor: 5.742

6.  Prevention of Fas-mediated hepatic failure by transferrin.

Authors:  Vladimir A Lesnikov; Marina P Lesnikova; Howard M Shulman; Heather-Marie Wilson; David M Hockenbery; Markus Kocher; Walter Pierpaoli; H Joachim Deeg
Journal:  Lab Invest       Date:  2004-03       Impact factor: 5.662

7.  Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Authors:  Sara C Meyer; Alix O'Meara; Andreas S Buser; André Tichelli; Jakob R Passweg; Martin Stern
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-23       Impact factor: 5.742

Review 8.  Systemic iron homeostasis.

Authors:  Tomas Ganz
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

9.  Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Authors:  Breno P Esposito; William Breuer; Pornpan Sirankapracha; Pensri Pootrakul; Chaim Hershko; Z Ioav Cabantchik
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Bmp6 expression can be regulated independently of liver iron in mice.

Authors:  Zhuzhen Zhang; Xin Guo; Carolina Herrera; Yunlong Tao; Qian Wu; Aimin Wu; Hao Wang; Thomas B Bartnikas; Fudi Wang
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

View more
  1 in total

Review 1.  Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.

Authors:  Erden Atilla; Selami K Toprak; Taner Demirer
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.